<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34194442</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>10</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Genetic Analysis of Tryptophan Metabolism Genes in Sporadic Amyotrophic Lateral Sclerosis.</ArticleTitle><Pagination><StartPage>701550</StartPage><MedlinePgn>701550</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">701550</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2021.701550</ELocationID><Abstract><AbstractText>The essential amino acid tryptophan (TRP) is the initiating metabolite of the kynurenine pathway (KP), which can be upregulated by inflammatory conditions in cells. Neuroinflammation-triggered activation of the KP and excessive production of the KP metabolite quinolinic acid are common features of multiple neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS). In addition to its role in the KP, genes involved in TRP metabolism, including its incorporation into proteins, and synthesis of the neurotransmitter serotonin, have also been genetically and functionally linked to these diseases. ALS is a late onset neurodegenerative disease that is classified as familial or sporadic, depending on the presence or absence of a family history of the disease. Heritability estimates support a genetic basis for all ALS, including the sporadic form of the disease. However, the genetic basis of sporadic ALS (SALS) is complex, with the presence of multiple gene variants acting to increase disease susceptibility and is further complicated by interaction with potential environmental factors. We aimed to determine the genetic contribution of 18 genes involved in TRP metabolism, including protein synthesis, serotonin synthesis and the KP, by interrogating whole-genome sequencing data from 614 Australian sporadic ALS cases. Five genes in the KP (<i>AFMID, CCBL1, GOT2, KYNU, HAAO</i>) were found to have either novel protein-altering variants, and/or a burden of rare protein-altering variants in SALS cases compared to controls. Four genes involved in TRP metabolism for protein synthesis (<i>WARS</i>) and serotonin synthesis (<i>TPH1, TPH2, MAOA</i>) were also found to carry novel variants and/or gene burden. These variants may represent ALS risk factors that act to alter the KP and lead to neuroinflammation. These findings provide further evidence for the role of TRP metabolism, the KP and neuroinflammation in ALS disease pathobiology.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Fifita, Chan Moi Fat, McCann, Williams, Twine, Bauer, Rowe, Pamphlett, Kiernan, Tan, Blair and Guillemin.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fifita</LastName><ForeName>Jennifer A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Macquarie University Centre for Motor Neuron Disease Research, Department of Biomedical Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan Moi Fat</LastName><ForeName>Sandrine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Macquarie University Centre for Motor Neuron Disease Research, Department of Biomedical Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCann</LastName><ForeName>Emily P</ForeName><Initials>EP</Initials><AffiliationInfo><Affiliation>Macquarie University Centre for Motor Neuron Disease Research, Department of Biomedical Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Kelly L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Macquarie University Centre for Motor Neuron Disease Research, Department of Biomedical Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Twine</LastName><ForeName>Natalie A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Macquarie University Centre for Motor Neuron Disease Research, Department of Biomedical Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Australian e-Health Research Centre, Commonwealth Scientific and Industrial Research Organization, Health &amp; Biosecurity Flagship, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bauer</LastName><ForeName>Denis C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Australian e-Health Research Centre, Commonwealth Scientific and Industrial Research Organization, Health &amp; Biosecurity Flagship, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Applied BioSciences, Faculty of Science and Engineering, Macquarie University, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rowe</LastName><ForeName>Dominic B</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Macquarie University Centre for Motor Neuron Disease Research, Department of Biomedical Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pamphlett</LastName><ForeName>Roger</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Discipline of Pathology, School of Medical Sciences, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuropathology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiernan</LastName><ForeName>Matthew C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Neurosciences, Royal Prince Alfred Hospital, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Vanessa X</ForeName><Initials>VX</Initials><AffiliationInfo><Affiliation>Macquarie University Centre for Motor Neuron Disease Research, Department of Biomedical Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blair</LastName><ForeName>Ian P</ForeName><Initials>IP</Initials><AffiliationInfo><Affiliation>Macquarie University Centre for Motor Neuron Disease Research, Department of Biomedical Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guillemin</LastName><ForeName>Gilles J</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>Macquarie University Centre for Motor Neuron Disease Research, Department of Biomedical Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS065847</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>8DUH1N11BX</RegistryNumber><NameOfSubstance UI="D014364">Tryptophan</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014364" MajorTopicYN="N">Tryptophan</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073336" MajorTopicYN="N">Whole Genome Sequencing</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">kynurenine pathway (KP)</Keyword><Keyword MajorTopicYN="N">serotonin</Keyword><Keyword MajorTopicYN="N">sporadic amyotrophic lateral sclerosis (SALS)</Keyword><Keyword MajorTopicYN="N">tryptophan</Keyword><Keyword MajorTopicYN="N">whole-genome sequence (WGS)</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34194442</ArticleId><ArticleId IdType="pmc">PMC8236844</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2021.701550</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Shefner JM, Al-Chalabi A, Baker MR, Cui L-Y, de Carvalho M, Eisen A, et al. . A Proposal for New Diagnostic Criteria for ALS. Clin Neurophysiol (2020) 131:1975&#x2013;8. &#xa0;10.1016/j.clinph.2020.04.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2020.04.005</ArticleId><ArticleId IdType="pubmed">32387049</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, et al. . Amyotrophic Lateral Sclerosis. Lancet (2017) 390:2084&#x2013;98. &#xa0;10.1016/S0140-6736(17)31287-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory JM, Fagegaltier D, Phatnani H, Harms MB. Genetics of Amyotrophic Lateral Sclerosis. Curr Genet Med Rep (2020) 8:121&#x2013;31. &#xa0;10.1007/s40142-020-00194-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40142-020-00194-8</ArticleId></ArticleIdList></Reference><Reference><Citation>McCann EP, Henden L, Fifita JA, Zhang KY, Grima N, Bauer DC, et al. . Evidence for Polygenic and Oligogenic Basis of Australian Sporadic Amyotrophic Lateral Sclerosis. J Med Genet (2021) 58:87&#x2013;95. &#xa0;10.1136/jmedgenet-2020-106866</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmedgenet-2020-106866</ArticleId><ArticleId IdType="pubmed">32409511</ArticleId></ArticleIdList></Reference><Reference><Citation>McCann EP, Williams KL, Fifita JA, Tarr IS, O&#x2019;Connor J, Rowe DB, et al. . The Genotype-Phenotype Landscape of Familial Amyotrophic Lateral Sclerosis in Australia. Clin Genet (2017) 92:259&#x2013;66. &#xa0;10.1111/cge.12973</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cge.12973</ArticleId><ArticleId IdType="pubmed">28105640</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis S, Goizet C, Soulages A, Vallat J-M, Masson GL. Genetics of Amyotrophic Lateral Sclerosis: A Review. J Neurol Sci (2019) 399:217&#x2013;26. &#xa0;10.1016/j.jns.2019.02.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2019.02.030</ArticleId><ArticleId IdType="pubmed">30870681</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Fang F, Hanby MF, Leigh PN, Shaw CE, Ye W, et al. . An Estimate of Amyotrophic Lateral Sclerosis Heritability Using Twin Data. J Neurol Neurosurg Psychiatry (2010) 81:1324&#x2013;6. &#xa0;10.1136/jnnp.2010.207464</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.207464</ArticleId><ArticleId IdType="pmc">PMC2988617</ArticleId><ArticleId IdType="pubmed">20861059</ArticleId></ArticleIdList></Reference><Reference><Citation>Wingo TS, Cutler DJ, Yarab N, Kelly CM, Glass JD. The Heritability of Amyotrophic Lateral Sclerosis in a Clinically Ascertained United States Research Registry. PloS One (2011) 6(11):e27985. &#xa0;10.1371/journal.pone.0027985 e.27985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0027985</ArticleId><ArticleId IdType="pmc">PMC3222666</ArticleId><ArticleId IdType="pubmed">22132186</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan M, Heverin M, McLaughlin RL, Hardiman O. Lifetime Risk and Heritability of Amyotrophic Lateral Sclerosis. JAMA Neurol (2019) 76:1367&#x2013;74. &#xa0;10.1001/jamaneurol.2019.2044</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2019.2044</ArticleId><ArticleId IdType="pmc">PMC6646974</ArticleId><ArticleId IdType="pubmed">31329211</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Calvo A, Chio A, Colville S, Ellis CM, Hardiman O, et al. . Analysis of Amyotrophic Lateral Sclerosis as a Multistep Process: A Population-Based Modelling Study. Lancet Neurol (2014) 13:1108&#x2013;13. &#xa0;10.1016/S1474-4422(14)70219-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70219-4</ArticleId><ArticleId IdType="pmc">PMC4197338</ArticleId><ArticleId IdType="pubmed">25300936</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Mazzini L, D&#x2019;Alfonso S, Corrado L, Canosa A, Moglia C, et al. . The Multistep Hypothesis of ALS Revisited. Neurology (2018) 91:e635&#x2013;42. &#xa0;10.1212/WNL.0000000000005996</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000005996</ArticleId><ArticleId IdType="pmc">PMC6105040</ArticleId><ArticleId IdType="pubmed">30045958</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli ET, Lasseigne BN, Petrovski S, Sapp PC, Dion PA, Leblond CS, et al. . Exome Sequencing in Amyotrophic Lateral Sclerosis Identifies Risk Genes and Pathways. Science (2015) 347(6229):1436&#x2013;41. &#xa0;10.1126/science.aaa3650</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa3650</ArticleId><ArticleId IdType="pmc">PMC4437632</ArticleId><ArticleId IdType="pubmed">25700176</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillemin GJ, Meininger V, Brew BJ. Implications for the Kynurenine Pathway and Quinolinic Acid in Amyotrophic Lateral Sclerosis. Neurodegener Dis (2006) 2:166&#x2013;76. &#xa0;10.1159/000089622</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000089622</ArticleId><ArticleId IdType="pubmed">16909022</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Stankovic R, Cullen KM, Meininger V, Garner B, Coggan S, et al. . The Kynurenine Pathway and Inflammation in Amyotrophic Lateral Sclerosis. Neurotox Res (2010) 18(2):132&#x2013;42. &#xa0;10.1007/s12640-009-9129-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-009-9129-7</ArticleId><ArticleId IdType="pubmed">19921535</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalisch BE, Jhamandas K, Boegman RJ, Beninger RJ. Picolinic Acid Protects Against Quinolinic Acid-Induced Depletion of NADPH Diaphorase Containing Neurons in the Rat Striatum. Brain Res (1994) 668:1&#x2013;8. &#xa0;10.1016/0006-8993(94)90504-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(94)90504-5</ArticleId><ArticleId IdType="pubmed">7535651</ArticleId></ArticleIdList></Reference><Reference><Citation>Maddison DC, Giorgini F. The Kynurenine Pathway and Neurodegenerative Disease. Semin Cell Dev Biol (2015) 40:134&#x2013;41. &#xa0;10.1016/j.semcdb.2015.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2015.03.002</ArticleId><ArticleId IdType="pubmed">25773161</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai PC, Soong BW, Mademan I, Huang YH, Liu CR, Hsiao CT, et al. . A Recurrent WARS Mutation is a Novel Cause of Autosomal Dominant Distal Hereditary Motor Neuropathy. Brain (2017) 140:1252&#x2013;66. &#xa0;10.1093/brain/awx058</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx058</ArticleId><ArticleId IdType="pmc">PMC6248622</ArticleId><ArticleId IdType="pubmed">28369220</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Li X, Huang S, Zhao H, Liu J, Hu Z, et al. . A Novel WARS Mutation (p.Asp314Gly) Identified in a Chinese Distal Hereditary Motor Neuropathy Family. Clin Genet (2019) 96:176&#x2013;82. &#xa0;10.1111/cge.13563</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cge.13563</ArticleId><ArticleId IdType="pubmed">31069783</ArticleId></ArticleIdList></Reference><Reference><Citation>Boros FA, Boh&#xe1;r Z, V&#xe9;csei L. Genetic Alterations Affecting the Genes Encoding the Enzymes of the Kynurenine Pathway and Their Association With Human Diseases. Mutat Res (2018) 776:32&#x2013;45. &#xa0;10.1016/j.mrrev.2018.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mrrev.2018.03.001</ArticleId><ArticleId IdType="pubmed">29807576</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim CK, Bilgin A, Lovejoy DB, Tan V, Bustamante S, Taylor BV, et al. . Kynurenine Pathway Metabolomics Predicts and Provides Mechanistic Insight Into Multiple Sclerosis Progression. Sci Rep (2017) 7:41473. &#xa0;10.1038/srep41473</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep41473</ArticleId><ArticleId IdType="pmc">PMC5290739</ArticleId><ArticleId IdType="pubmed">28155867</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim CK, Fern&#xe1;ndez-Gomez FJ, Braidy N, Estrada C, Costa C, Costa S, et al. . Involvement of the Kynurenine Pathway in the Pathogenesis of Parkinson&#x2019;s Disease. Prog Neurobiol (2017) 155:76&#x2013;95. &#xa0;10.1016/j.pneurobio.2015.12.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2015.12.009</ArticleId><ArticleId IdType="pubmed">27072742</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillemin GJ, Brew BJ, Noonan CE, Takikawa O, Cullen KM. Indoleamine 2,3 Dioxygenase and Quinolinic Acid Immunoreactivity in Alzheimer&#x2019;s Disease Hippocampus. Neuropathol Appl Neurobiol (2005) 31:395&#x2013;404. &#xa0;10.1111/j.1365-2990.2005.00655.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2990.2005.00655.x</ArticleId><ArticleId IdType="pubmed">16008823</ArticleId></ArticleIdList></Reference><Reference><Citation>I&#x142;zecka J, Kocki T, Stelmasiak Z, Turski WA. Endogenous Protectant Kynurenic Acid in Amyotrophic Lateral Sclerosis. Acta Neurol Scand (2003) 107:412&#x2013;8. &#xa0;10.1034/j.1600-0404.2003.00076.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-0404.2003.00076.x</ArticleId><ArticleId IdType="pubmed">12757473</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan VX, Guillemin GJ. Kynurenine Pathway Metabolites as Biomarkers for Amyotrophic Lateral Sclerosis. Front Neurosci (2019) 10:1013. &#xa0;10.3389/fnins.2019.01013</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01013</ArticleId><ArticleId IdType="pmc">PMC6764462</ArticleId><ArticleId IdType="pubmed">31616242</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial Revisited: Revised Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis. Amyotroph Lateral Scler (2000) 1:293&#x2013;9. &#xa0;10.1080/146608200300079536</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. . Analysis of Protein-Coding Genetic Variation in 60,706 Humans. Nature (2016) 536:285&#x2013;91. &#xa0;10.1038/nature19057</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature19057</ArticleId><ArticleId IdType="pmc">PMC5018207</ArticleId><ArticleId IdType="pubmed">27535533</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinese M, Lacaze P, Rath EM, Stone A, Brion M-J, Ameur A, et al. . The Medical Genome Reference Bank Contains Whole Genome and Phenotype Data of 2570 Healthy Elderly. Nat Commun (2020) 11:435. &#xa0;10.1038/s41467-019-14079-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-14079-0</ArticleId><ArticleId IdType="pmc">PMC6978518</ArticleId><ArticleId IdType="pubmed">31974348</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K, Li M, Hakonarson H. Annovar: Functional Annotation of Genetic Variants From High-Throughput Sequencing Data. Nucleic Acids Res (2010) 38:e164. &#xa0;10.1093/nar/gkq603</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkq603</ArticleId><ArticleId IdType="pmc">PMC2938201</ArticleId><ArticleId IdType="pubmed">20601685</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Wu C, Li C, Boerwinkle E. dbNSFP V3.0: A One-Stop Database of Functional Predictions and Annotations for Human Nonsynonymous and Splice-Site Snvs. Hum Mutat (2016) 37:235&#x2013;41. &#xa0;10.1002/humu.22932</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.22932</ArticleId><ArticleId IdType="pmc">PMC4752381</ArticleId><ArticleId IdType="pubmed">26555599</ArticleId></ArticleIdList></Reference><Reference><Citation>Trost B, Walker S, Wang Z, Thiruvahindrapuram B, MacDonald JR, Sung WWL, et al. . A Comprehensive Workflow for Read Depth-Based Identification of Copy-Number Variation From Whole-Genome Sequence Data. Am J Hum Genet (2018) 102:142&#x2013;55. &#xa0;10.1016/j.ajhg.2017.12.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2017.12.007</ArticleId><ArticleId IdType="pmc">PMC5777982</ArticleId><ArticleId IdType="pubmed">29304372</ArticleId></ArticleIdList></Reference><Reference><Citation>
RStudio Team . Rstudio: Integrated Development for R (2010). Available at: http://www.rstudio.com.</Citation></Reference><Reference><Citation>Robinson JT, Thorvaldsd&#xf3;ttir H, Winckler W, Guttman M, Lander ES, Getz G, et al. . Integrative Genomics Viewer. Nat Biotechnol (2011) 29:24&#x2013;6. &#xa0;10.1038/nbt.1754</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1754</ArticleId><ArticleId IdType="pmc">PMC3346182</ArticleId><ArticleId IdType="pubmed">21221095</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S, et al. . Revel: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants. Am J Hum Genet (2016) 99:877&#x2013;85. &#xa0;10.1016/j.ajhg.2016.08.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2016.08.016</ArticleId><ArticleId IdType="pmc">PMC5065685</ArticleId><ArticleId IdType="pubmed">27666373</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng B-J. Perch: A Unified Framework for Disease Gene Prioritization. Hum Mutat (2017) 38:243&#x2013;51. &#xa0;10.1002/humu.23158</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.23158</ArticleId><ArticleId IdType="pmc">PMC5299048</ArticleId><ArticleId IdType="pubmed">27995669</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y, Pesaran T, Chamberlin A, Fenwick RB, Li S, Gau C-L, et al. . REVEL and BayesDel Outperform Other In Silico Meta-Predictors for Clinical Variant Classification. Sci Rep (2019) 9:12752. &#xa0;10.1038/s41598-019-49224-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-49224-8</ArticleId><ArticleId IdType="pmc">PMC6726608</ArticleId><ArticleId IdType="pubmed">31484976</ArticleId></ArticleIdList></Reference><Reference><Citation>Desmet F-O, Hamroun D, Lalande M, Collod-B&#xe9;roud G, Claustres M, B&#xe9;roud C. Human Splicing Finder: An Online Bioinformatics Tool to Predict Splicing Signals. Nucleic Acids Res (2009) 37:e67. &#xa0;10.1093/nar/gkp215</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkp215</ArticleId><ArticleId IdType="pmc">PMC2685110</ArticleId><ArticleId IdType="pubmed">19339519</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Rheenen W, Pulit SL, Dekker AM, Al Khleifat A, Brands WJ, Iacoangeli A, et al. . Project MinE: Study Design and Pilot Analyses of a Large-Scale Whole-Genome Sequencing Study in Amyotrophic Lateral Sclerosis. Eur J Hum Genet (2018) 26:1537&#x2013;46. &#xa0;10.1038/s41431-018-0177-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41431-018-0177-4</ArticleId><ArticleId IdType="pmc">PMC6138692</ArticleId><ArticleId IdType="pubmed">29955173</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CY, Chien CI, Chang CP, Lin BC, Wang CC. A WHEP Domain Regulates the Dynamic Structure and Activity of Caenorhabditis elegans glycyl-tRNA Synthetase. J Biol Chem (2016) 291:16567&#x2013;75. &#xa0;10.1074/jbc.M116.730812</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M116.730812</ArticleId><ArticleId IdType="pmc">PMC4974372</ArticleId><ArticleId IdType="pubmed">27298321</ArticleId></ArticleIdList></Reference><Reference><Citation>Lovelace MD, Varney B, Sundaram G, Lennon MJ, Lim CK, Jacobs K, et al. . Recent Evidence for an Expanded Role of the Kynurenine Pathway of Tryptophan Metabolism in Neurological Diseases. Neuropharmacology (2017) 112:373&#x2013;88. &#xa0;10.1016/j.neuropharm.2016.03.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2016.03.024</ArticleId><ArticleId IdType="pubmed">26995730</ArticleId></ArticleIdList></Reference><Reference><Citation>Myint AM, Kim YK. Cytokine-Serotonin Interaction Through IDO: A Neurodegeneration Hypothesis of Depression. Med Hypotheses (2003) 61:519&#x2013;25. &#xa0;10.1016/S0306-9877(03)00207-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0306-9877(03)00207-X</ArticleId><ArticleId IdType="pubmed">14592780</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Spreux-Varoquaux O, Bensimon G, Jullien P, Lacomblez L, Salachas F, et al. . Platelet Serotonin Level Predicts Survival in Amyotrophic Lateral Sclerosis. PloS One (2010) 5:e13346. &#xa0;10.1371/journal.pone.0013346</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013346</ArticleId><ArticleId IdType="pmc">PMC2954194</ArticleId><ArticleId IdType="pubmed">20967129</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandyk R. Serotonergic Mechanisms in Amyotrophic Lateral Sclerosis. Int J Neurosci (2006) 116:775&#x2013;826. &#xa0;10.1080/00207450600754087</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00207450600754087</ArticleId><ArticleId IdType="pubmed">16861147</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner BJ, Lopes EC, Cheema SS. The Serotonin Precursor 5-Hydroxytryptophan Delays Neuromuscular Disease in Murine Familial Amyotrophic Lateral Sclerosis. Amyotroph Lateral Scler Other Mot Neuron Disord (2003) 4:171&#x2013;76. &#xa0;10.1080/14660820310009389</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820310009389</ArticleId><ArticleId IdType="pubmed">14527871</ArticleId></ArticleIdList></Reference><Reference><Citation>El Oussini H, Scekic-Zahirovic J, Vercruysse P, Marques C, Dirrig-Grosch S, Dieterl&#xe9; S, et al. . Degeneration of Serotonin Neurons Triggers Spasticity in Amyotrophic Lateral Sclerosis. Ann Neurol (2017) 82:444&#x2013;56. &#xa0;10.1002/ana.25030</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25030</ArticleId><ArticleId IdType="pubmed">28856708</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs KR, Lovejoy DB. Inhibiting the Kynurenine Pathway in Spinal Cord Injury: Multiple Therapeutic Potentials? Neural Regener Res (2018) 13:2073&#x2013;6. &#xa0;10.4103/1673-5374.241446</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.241446</ArticleId><ArticleId IdType="pmc">PMC6199950</ArticleId><ArticleId IdType="pubmed">30323124</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JM, Tan V, Lovejoy D, Braidy N, Rowe DB, Brew BJ, et al. . Involvement of Quinolinic Acid in the Neuropathogenesis of Amyotrophic Lateral Sclerosis. Neuropharmacology (2017) 112:346&#x2013;64. &#xa0;10.1016/j.neuropharm.2016.05.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2016.05.011</ArticleId><ArticleId IdType="pubmed">27265569</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillemin GJ. Quinolinic Acid, the Inescapable Neurotoxin. FEBS J (2012) 279:1356&#x2013;65. &#xa0;10.1111/j.1742-4658.2012.08485.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2012.08485.x</ArticleId><ArticleId IdType="pubmed">22248144</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn LI, Miller TM, Cleveland DW. Unraveling the Mechanisms Involved in Motor Neuron Degeneration in ALS. Annu Rev Neurosci (2004) 27:723&#x2013;49. &#xa0;10.1146/annurev.neuro.27.070203.144244</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.neuro.27.070203.144244</ArticleId><ArticleId IdType="pubmed">15217349</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillemin GJ, Kerr SJ, Smythe GA, Smith DG, Kapoor V, Armati PJ, et al. . Kynurenine Pathway Metabolism in Human Astrocytes: A Paradox for Neuronal Protection. J Neurochem (2001) 78:842&#x2013;53. &#xa0;10.1046/j.1471-4159.2001.00498.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2001.00498.x</ArticleId><ArticleId IdType="pubmed">11520905</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>